Please login to the form below

Not currently logged in
Email:
Password:

TEVA-48125

This page shows the latest TEVA-48125 news and features for those working in and with pharma, biotech and healthcare.

Teva says chronic migraine drug is ready for phase III

Teva says chronic migraine drug is ready for phase III

Teva says chronic migraine drug is ready for phase III. TEV-48125 efficacy “ has not previously been achieved”. ... Teva's novel migraine drug TEV-48125 should start phase III trials shortly, after showing 'unprecedented' activity in a mid-stage study

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics